Agilent Technologies, Inc. (A)
167.78
+1.10
(+0.66%)
USD |
NYSE |
Oct 02, 16:00
167.80
+0.02
(+0.01%)
Pre-Market: 20:00
Agilent Technologies Enterprise Value : 49.50B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 49.50B |
| October 01, 2026 | 49.19B |
| September 30, 2026 | 50.78B |
| September 29, 2026 | 51.54B |
| September 28, 2026 | 51.59B |
| September 25, 2026 | 50.91B |
| September 24, 2026 | 50.93B |
| September 23, 2026 | 48.81B |
| September 22, 2026 | 49.35B |
| September 21, 2026 | 47.85B |
| September 18, 2026 | 46.31B |
| September 17, 2026 | 46.27B |
| September 16, 2026 | 45.53B |
| September 15, 2026 | 44.56B |
| September 14, 2026 | 43.58B |
| September 11, 2026 | 43.62B |
| September 10, 2026 | 42.55B |
| September 09, 2026 | 43.01B |
| September 08, 2026 | 43.60B |
| September 04, 2026 | 44.73B |
| September 03, 2026 | 44.48B |
| September 02, 2026 | 44.88B |
| September 01, 2026 | 44.47B |
| August 31, 2026 | 45.49B |
| August 28, 2026 | 45.57B |
| Date | Value |
|---|---|
| August 27, 2026 | 46.65B |
| August 26, 2026 | 45.92B |
| August 25, 2026 | 45.83B |
| August 24, 2026 | 45.45B |
| August 21, 2026 | 47.02B |
| August 20, 2026 | 46.26B |
| August 19, 2026 | 46.01B |
| August 18, 2026 | 44.05B |
| August 17, 2026 | 44.05B |
| August 14, 2026 | 44.07B |
| August 13, 2026 | 44.29B |
| August 12, 2026 | 43.99B |
| August 11, 2026 | 44.34B |
| August 10, 2026 | 44.12B |
| August 07, 2026 | 43.35B |
| August 06, 2026 | 42.04B |
| August 05, 2026 | 41.98B |
| August 04, 2026 | 41.44B |
| August 03, 2026 | 41.61B |
| July 31, 2026 | 41.21B |
| July 30, 2026 | 40.69B |
| July 29, 2026 | 41.14B |
| July 28, 2026 | 41.21B |
| July 27, 2026 | 40.46B |
| July 24, 2026 | 40.65B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Thermo Fisher Scientific, Inc. | 280.71B |
| Danaher Corp. | 173.98B |
| Illumina, Inc. | 42.59B |
| Bio-Rad Laboratories, Inc. | 9.620B |
| Revvity, Inc. | 19.23B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 362.00M |
| Revenue (Quarterly) | 1.878B |
| Total Expenses (Quarterly) | 1.516B |
| EPS Diluted (Quarterly) | 1.279 |
| Gross Profit Margin (Quarterly) | 55.48% |
| Profit Margin (Quarterly) | 19.28% |
| Earnings Yield | 3.03% |
| Operating Earnings Yield | 3.73% |
| Normalized Earnings Yield | 3.251 |